Sanofi (SNY)
39.92
-0.75
(-1.84%)
USD |
NASDAQ |
Oct 02, 16:00
39.90
-0.02
(-0.04%)
After-Hours: 20:00
Sanofi Price to Book Value : 1.345 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.345 |
| October 01, 2026 | 1.370 |
| September 30, 2026 | 1.389 |
| September 29, 2026 | 1.372 |
| September 28, 2026 | 1.387 |
| September 25, 2026 | 1.385 |
| September 24, 2026 | 1.379 |
| September 23, 2026 | 1.403 |
| September 22, 2026 | 1.432 |
| September 21, 2026 | 1.432 |
| September 18, 2026 | 1.431 |
| September 17, 2026 | 1.453 |
| September 16, 2026 | 1.435 |
| September 15, 2026 | 1.428 |
| September 14, 2026 | 1.460 |
| September 11, 2026 | 1.441 |
| September 10, 2026 | 1.439 |
| September 09, 2026 | 1.444 |
| September 08, 2026 | 1.454 |
| September 04, 2026 | 1.490 |
| September 03, 2026 | 1.493 |
| September 02, 2026 | 1.498 |
| September 01, 2026 | 1.495 |
| August 31, 2026 | 1.494 |
| August 28, 2026 | 1.510 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.510 |
| August 26, 2026 | 1.530 |
| August 25, 2026 | 1.550 |
| August 24, 2026 | 1.539 |
| August 21, 2026 | 1.545 |
| August 20, 2026 | 1.521 |
| August 19, 2026 | 1.544 |
| August 18, 2026 | 1.515 |
| August 17, 2026 | 1.496 |
| August 14, 2026 | 1.473 |
| August 13, 2026 | 1.475 |
| August 12, 2026 | 1.472 |
| August 11, 2026 | 1.467 |
| August 10, 2026 | 1.465 |
| August 07, 2026 | 1.464 |
| August 06, 2026 | 1.445 |
| August 05, 2026 | 1.441 |
| August 04, 2026 | 1.438 |
| August 03, 2026 | 1.447 |
| July 31, 2026 | 1.451 |
| July 30, 2026 | 1.445 |
| July 29, 2026 | 1.511 |
| July 28, 2026 | 1.534 |
| July 27, 2026 | 1.482 |
| July 24, 2026 | 1.460 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.28 |
| GSK Plc | 4.062 |
| Johnson & Johnson | 7.256 |
| Eli Lilly & Co. | 31.76 |
| Merck & Co., Inc. | 8.495 |
Price to Book Value Related Metrics
| PE Ratio | 20.56 |
| PS Ratio | 1.804 |
| PEG Ratio | 2.920 |
| Price to Free Cash Flow | 9.756 |
| Price | 39.92 |
| Earnings Yield | 4.86% |
| Market Cap | 96.93B |
| PEGY Ratio | 1.568 |
| Operating PE Ratio | 6.639 |
| Normalized PE Ratio | 11.62 |